| abstract |
Novel compositions are provided which comprise recombinantly-produced targeting components capable of binding to cell membrane constituents linked, such as by polypeptide linkers, to toxin components capable of killing cells by damaging their cellular membranes. The conjugates may find use, e.g., in novel methods for selectively killing predetermined cell populations in an individual or in in vitro cell cultures. |